Westat Expertise at 2020 Clinical Trials Strategic Summit

Westat experts provided knowledge and insight at the virtual 4th Clinical Trials Strategic Summit, held on Friday, May 15, 2020.

Deepak Khatry, Ph.D., a Westat Associate Director and Biostatistical Lead for Clinical Trials, was a featured speaker. Other virtual attendees from Westat included Nancy Dianis, Vice President and Practice Director for Clinical Trials; Melissa King, Vice President; Brenda Brewer, Associate Director; Bob Harris, Associate Director; and Whitney Smith, Data Management Lead.

Dr. Khatry’s presentation, Using Simulation to Estimate Potential Efficacy, Effectiveness, and Probability of Success in Biomarker-Stratified Clinical Trial Designs, was given to a global audience of biotech and pharmaceutical representatives interested in ensuring high-quality clinical trials.

Learn more on how Westat can support your clinical trials research needs:

Clinical Trial Services in Support of SARS-CoV-2 Research (PDF). Westat is a leader in designing, managing, monitoring, and delivering advanced clinical trials and epidemiologic studies. We support clinical research in emerging infectious diseases, such as SARS-CoV-2, Zika, and influenza as well as chronic and infectious diseases, including HIV/AIDS, cancer, and tuberculosis.

Clinical Data Interchange Standards Consortium (CDISC) (PDF). Enabling the interoperability of information systems is key to informing health care research. Westat provides CDISC-compliant data so that your study moves efficiently through the Food and Drug Administration’s (FDA’s) submission process.

Designing & Implementing Studies Using Medidata Rave’s Unified Clinical Trial Platform (PDF). As a Medidata partner, Westat uses a full suite of Rave solutions offered on a single unified study platform. Our clients benefit from the process efficiencies of this approach and have peace of mind that Westat data services adhere to the highest industry standards.

Data Management & Database Development Services (PDF). Westat performs comprehensive data services, ensuring a prompt response to your study-specific needs, achievement of your study goals, and the fluid submission of your study to the FDA.

Study Design and Statistical Analysis (PDF). Westat provides clients with innovative, comprehensive study design and statistical analysis services. We provide solutions to meet the needs of a wide variety of products in various stages of the clinical development pipeline and to support regulatory submissions.

 

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
SiriusXM
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
Toyota
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2021 The Best Employers for Diversity Powered by StatistaForbes 2021: America's Best Midsize Employer Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.